Cell and gene therapy CRO market Size, Share, Trends by 2035

  • In the last few years, many contract research organizations (CROs) have emerged and significantly impacted the overall biopharmaceutical market.







    It is worth mentioning that the presence of CROs has enabled small and mid-sized companies, which lack the necessary expertise and elaborate resources, to successfully initiate R&D programs in several domains.







    The financial opportunity within the Cell and Gene Therapy CROs Market has been analyzed across the following segments:

    • Area of Expertise
    • Cell Therapy
    • Gene Therapy
    • Scale of Operation
    • Preclinical
    • Clinical
    • Drug Discovery
    • Therapeutic Area
    • Oncological Disorders
    • Neurological Disorders
    • Cardiovascular Disorders
    • Infectious Diseases
    • Metabolic Disorders
    • Autoimmune Disorders
    • Blood Disorders
    • Rare / Genetic Disorders
    • Ophthalmic Disorders
    • Other disorders
    • Analysis by Geographical Regions
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and North Africa























































    The Cell and Gene Therapy CROs Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:

    • Altasciences
    • Charles River Laboratories
    • Creative Biolabs
    • IQVIA
    • Medpace
    • PPD
    • Precision for Medicine
    • Accelera
    • Evotec
    • ICON
    • Syneos Health
    • CMIC Group
    • Labcorp




    Table of Contents







    1. Preface






    2. Executive Summary







    3. Introduction







    4. Guide To Outsourcing







    5. Market Landscape







    6. Company Profiles







    7. Competitive Benchmarking







    8. Partnerships And Collaborations







    9. Mergers and Acquisitions







    10. Key Acquisition Targets







    11. Likely Partner Analysis for Cell Therapy CROs







    12. Likely Partner Analysis for Gene Therapy CROs







    13. Clinical Trial Analysis







    14. Total Cost of Ownership for Cell and Gene Therapy Contract Research Organizations







    15. Market Forecast and Opportunity Analysis







    16. Swot Analysis







    17. Conclusion







    18. Interview And Survey Transcripts







    19. Appendix 1: Tabulated Data







    20. Appendix 2: List of Companies and Organizations







    To view more details on this report, click on the link:




    https://www.rootsanalysis.com/…rapy-cros-market/230.html







    You may also be interested in the following titles:







    You may also like to learn what our experts are sharing in Roots educational series:




    Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?







    Artificial Intelligence (AI) In Oncology: Current Scenario And Future Potential







    About Roots Analysis




    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.




                           




    Contact:




    Ben Johnson




    +1 (415) 800 3415


    Ben.johnson@rootsanalysis.com

Letzte Aktivitäten

Jetzt mitmachen!

Sie haben noch kein Benutzerkonto auf unserer Seite? Registrieren Sie sich kostenlos und nehmen Sie an unserer Community teil!